VERU INC. Number of Reportable Segments
VERU INC. (VERU) reported Number of Reportable Segments of 100.00% for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-10
- VERU INC. number of reportable segments for fiscal 2013 was 100.00%, a 0.00% change from fiscal 2012.
- VERU INC. number of reportable segments for fiscal 2012 was 100.00%.
pure
| Period end | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|
| 2026-06-30 | 100.00% 10-Q · filed 2026-08-10 | |
| 2013-09-30 | 100.00% 10-K · filed 2013-12-03 | |
| 2012-09-30 | 100.00% 10-K · filed 2012-12-04 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2021-12-31 | 2.00 segment 10-Q · filed 2022-02-09 | |||
| 2021-09-30 | 2.00 segment 10-K · filed 2021-12-02 | |||
| 2021-06-30 | 2.00 segment 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 2.00 segment 10-Q · filed 2021-05-12 | |||
| 2020-12-31 | 2.00 segment 10-Q · filed 2021-02-10 | |||
| 2020-09-30 | 2.00 segment 10-K · filed 2020-12-10 | |||
| 2020-06-30 | 2.00 segment 10-Q · filed 2020-08-13 | |||
| 2020-03-31 | 2.00 segment 10-Q · filed 2020-05-13 | |||
| 2019-12-31 | 2.00 segment 10-Q · filed 2020-02-12 | |||
| 2019-09-30 | 2.00 segment 10-K · filed 2019-12-12 | |||
| 2019-06-30 | 2.00 segment 10-Q · filed 2019-08-08 | |||
| 2018-09-30 | 2.00 segment 10-K · filed 2018-12-13 | |||
| 2018-06-30 | 2.00 segment 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | 2.00 segment 10-Q · filed 2018-05-11 | |||
| 2017-12-31 | 2.00 segment 10-Q · filed 2018-02-14 | |||
| 2017-09-30 | 2.00 segment 10-K · filed 2018-01-02 | |||
| 2017-06-30 | 1.00 segment 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | 1.00 segment 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | 1.00 segment 10-Q · filed 2017-02-09 | |||
| 2016-09-30 | 1.00 segment 10-K · filed 2016-12-12 | |||
| 2015-12-31 | 1.00 segment 10-Q · filed 2016-02-02 | |||
| 2015-09-30 | 1.00 segment 10-K · filed 2015-12-02 | |||
| 2015-06-30 | 1.00 segment 10-Q · filed 2015-07-30 | |||
| 2015-03-31 | 1.00 segment 10-Q · filed 2015-04-30 | |||
| 2014-12-31 | 1.00 segment 10-Q · filed 2015-02-03 | |||
| 2014-09-30 | 1.00 segment 10-K · filed 2014-12-02 | |||
| 2014-06-30 | 1.00 segment 10-Q · filed 2014-07-31 | |||
| 2014-03-31 | 1.00 segment 10-Q · filed 2014-05-01 | |||
| 2013-12-31 | 1.00 segment 10-Q · filed 2014-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |